Bayer Gets Innovative: 2015's Digital Health Start-Ups Initiated Into Grant Program
This article was originally published in Scrip
Executive Summary
For a second year, Bayer Healthcare has launched its "Grants4Apps" program, which aims to offer financial support and business expertise to digital health start-up companies – an area of development it describes as a "very vibrant."
You may also be interested in...
Green Shoots: Pharma Investments In Early Innovation Support Biotech Growth
Big pharma investments in early innovation are paying off in ways that still are hard to measure in any concrete way, but green shoots are sprouting through the pavement as startups supported by multimillion-dollar initiatives evolve from concept to reality.
Bayer's CoLaborator: A Startup Hub In San Francisco's Biotech Cluster
Bayer is incubating startups and nurturing companies that could be the big pharma's next partners at its CoLaborator in San Francisco's Mission Bay, the heart of the region's biotech hub.
Finding Value Left On The Shelf: Karuna Case Study
PureTech’s gamble to take an older Eli Lilly drug off the shelf to redevelop in a new indication paid off. The company aims to replicate this 'Karuna model' in the near future.